![]() ![]() The home analyzer miniaturizes lab equipment for home use, and brings down the cost. To solve this problem, the team worked to develop the Mira system, which includes a small home analyzer, urine test strips, and an accompanying mobile application. The only way to accurately track fertile days, then, is through continuous testing – something that’s been difficult to do at home. She says that women’s hormones are changing daily, and everyone’s profiles differ due to their lifestyle, stress levels and other factors. Kang received an MBA at Cornell Johnson, went to Columbia for an MS in Biomedical engineering and received at PhD in Biophysics from University of Pittsburgh, before working as a Business Director at Corning where she was responsible for $100 million in global P&L, which she left to start Mira. “But there’s no education for them about when to try for a baby, and they have no awareness about their fertility health,” she says. “I have a lot of friends who, like me, their career advancement and higher education, and they tended to delay their maternal age,” explains Mira co-founder and CEO Sylvia Kang. The company behind Mira, Quanovate, was founded in late 2015 by a group of scientists, engineers, OBGYN doctors, and business execs to solve the problem of the unavailability of advanced home health testing. The system is more advanced and accurate than the existing home test kits, the company claims, which can be hard to read and aren’t personalized to the individual. The Mira Fertility system offers personalized cycle prediction by measuring fertility hormone concentrations in urine samples, telling women which days they’re fertile. Mira, launching today at TechCrunch Disrupt SF 2018, is a new device that aims to help women who are struggling to conceive.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |